BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 7981645)

  • 1. [Regulation of liberation and metabolism of dopamine in the dorsal striatum of free-living rats: the role of D2- and D3-dopamine autoreceptors].
    Gaĭnetdinov RR; Sotnikova TD; Grekhova TV; Raevskiĭ KS
    Dokl Akad Nauk; 1994 Aug; 337(6):821-3. PubMed ID: 7981645
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of intrastriatal infusion of D2 and D3 dopamine receptor preferring antagonists on dopamine release in rat dorsal striatum (in vivo microdialysis study).
    Sotnikova TD; Gainetdinov RR; Grekhova TV; Rayevsky KS
    Pharmacol Res; 2001 Mar; 43(3):283-90. PubMed ID: 11401421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dopamine D3 receptor and autoreceptor preferring antagonists (+)-AJ76 and (+)-UH232; a microdialysis study.
    Waters N; Lagerkvist S; Löfberg L; Piercey M; Carlsson A
    Eur J Pharmacol; 1993 Sep; 242(2):151-63. PubMed ID: 8253112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracerebral infusion of (+)-AJ76 and (+)-UH232: effects on dopamine release and metabolism in vivo.
    Waters N; Hansson L; Löfberg L; Carlsson A
    Eur J Pharmacol; 1994 Jan; 251(2-3):181-90. PubMed ID: 8149975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: II. Both D2 and "silent" D3 autoreceptors control synthesis and release in mesolimbic, mesocortical and nigrostriatal pathways.
    Gobert A; Rivet JM; Audinot V; Cistarelli L; Spedding M; Vian J; Peglion JL; Millan MJ
    J Pharmacol Exp Ther; 1995 Nov; 275(2):899-913. PubMed ID: 7473181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dopamine autoreceptors subtype D3 predominantly regulate the liberation of dopamine in rat brain basal ganglia].
    Sotnikova TD; Gaĭnetdinov RR; Grekhova TV; Raevskiĭ KS
    Biull Eksp Biol Med; 1996 Apr; 121(4):430-4. PubMed ID: 8829459
    [No Abstract]   [Full Text] [Related]  

  • 7. The 5-HT1A receptor antagonist (S)-UH-301 decreases dopamine release in the rat nucleus accumbens and striatum.
    Nomikos GG; Arborelius L; Höök BB; Hacksell U; Svensson TH
    J Neural Transm (Vienna); 1996; 103(5):541-54. PubMed ID: 8811500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine D2 and D3 receptor preferring antagonists differentially affect striatal dopamine release and metabolism in conscious rats.
    Gainetdinov RR; Grekhova TV; Sotnikova TD; Rayevsky KS
    Eur J Pharmacol; 1994 Aug; 261(3):327-31. PubMed ID: 7813556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine D3-preferring ligands act at synthesis modulating autoreceptors.
    Aretha CW; Sinha A; Galloway MP
    J Pharmacol Exp Ther; 1995 Aug; 274(2):609-13. PubMed ID: 7636720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo evidence for preferential role of dopamine D3 receptor in the presynaptic regulation of dopamine release but not synthesis.
    Gainetdinov RR; Sotnikova TD; Grekhova TV; Rayevsky KS
    Eur J Pharmacol; 1996 Jul; 308(3):261-9. PubMed ID: 8858296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological and immunochemical evidence of the dopamine D3 receptor in the goat carotid body.
    Wang ZY; Herman JK; O'Halloran KD; Keith IM; Bisgard GE
    Adv Exp Med Biol; 2001; 499():49-53. PubMed ID: 11729932
    [No Abstract]   [Full Text] [Related]  

  • 12. Modulation of mesolimbic dopamine release by the selective dopamine D3 receptor antagonist, (+)-S 14297.
    Rivet JM; Audinot V; Gobert A; Peglion JL; Millan MJ
    Eur J Pharmacol; 1994 Nov; 265(3):175-7. PubMed ID: 7875234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine D2 receptor-deficient mice exhibit decreased dopamine transporter function but no changes in dopamine release in dorsal striatum.
    Dickinson SD; Sabeti J; Larson GA; Giardina K; Rubinstein M; Kelly MA; Grandy DK; Low MJ; Gerhardt GA; Zahniser NR
    J Neurochem; 1999 Jan; 72(1):148-56. PubMed ID: 9886065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antagonism of cocaine's pharmacological effects by the stimulant dopaminergic antagonists, (+)-AJ76 and (+)-UH232.
    Piercey MF; Lum JT; Hoffmann WE; Carlsson A; Ljung E; Svensson K
    Brain Res; 1992 Aug; 588(2):217-22. PubMed ID: 1393576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pharmacological analysis of the effects of (+)-AJ 76 and (+)-UH 232 at release regulating pre- and postsynaptic dopamine receptors.
    Gifford AN; Johnson KM
    Eur J Pharmacol; 1993 Jun; 237(2-3):169-75. PubMed ID: 8103459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positron emission tomography (PET) study: the effects of 6R-L-erythro-5,6,7,8-tetrahydrobiopterin (R-THBP, SUN 0588) on the central dopamine D1, D2 and D3 receptors in rhesus monkey.
    Tani Y; Ishihara T; Kanai T; Ohno T; Onoe H; Watanabe Y; Andersson J; Lilija A; Westerberg G; Hartvig P
    Adv Exp Med Biol; 1993; 338():327-30. PubMed ID: 8304130
    [No Abstract]   [Full Text] [Related]  

  • 17. Dopamine autoreceptor reserve in vitro: possible role of dopamine D3 receptors.
    Aretha CW; Galloway MP
    Eur J Pharmacol; 1996 Jun; 305(1-3):119-22. PubMed ID: 8813541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of dopamine release and metabolism in rat striatum in vivo: effects of dopamine receptor antagonists.
    Rayevsky KS; Gainetdinov RR; Grekhova TV; Sotnikova TD
    Prog Neuropsychopharmacol Biol Psychiatry; 1995 Dec; 19(8):1285-1303. PubMed ID: 8868210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early administration of tiapride to young rats without long-lasting changes in the development of the dopaminergic system.
    Bock N; Moll GH; Wicker M; Pilz J; Rüther E; Banaschewski T; Huether G; Rothenberger A
    Pharmacopsychiatry; 2004 Jul; 37(4):163-7. PubMed ID: 15467972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement by ipsapirone of dopamine release in the rat striatum.
    Gołembiowska K; Wedzony K
    Pol J Pharmacol; 1993; 45(3):299-308. PubMed ID: 7693136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.